BIOMERIEUX (EPA:BIM) | Finanzwire

Basculer en Français

10700	Companies
228700	Keywords
157302	Articles
121376	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 03/14/2024 at 07:01, 2 years 3 months ago

bioMérieux – 2023 Financial Results
BRIEF

published on 03/04/2024 at 11:42, 2 years 4 months ago

BioMérieux announces its voting rights figures for February 2024

Share Capital Voting Rights BioMérieux Regulation February 2024
REGULATED PRESS RELEASE

published on 01/16/2024 at 07:01, 2 years 5 months ago

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D
bioMérieux, a world leader in in vitro diagnostics, announces the appointment of two new Executive Committee members, Dr. Charles K. Cooper and Céline Roger-Dalbert, to lead Medical Affairs and Research & Development, respectively. Dr. Cooper brings extensive medical and leadership background from Siemens Healthcare Diagnostics and U.S. Food & Drug Administration, while Céline Roger-Dalbert boasts over 25 years of in vitro diagnostic experience, with significant contributions to new product launches and over 20 patent applications. Their nominations signify bioMérieux's commitment to addressing global patients' needs and driving innovation, aligning with the company's strategy. For more information, visit www.biomerieux.com.

BioMérieux Medical Affairs Research And Development In Vitro Diagnostics Executive Committee Members
REGULATED PRESS RELEASE

published on 01/08/2024 at 08:22, 2 years 6 months ago

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions.

BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
REGULATED PRESS RELEASE

published on 10/26/2023 at 07:01, 2 years 8 months ago

bioMérieux – Third-Quarter 2023 Business Review
REGULATED PRESS RELEASE

published on 10/19/2023 at 08:00, 2 years 8 months ago

bioMérieux makes strategic investment in Oxford Nanopore
REGULATED PRESS RELEASE

published on 10/13/2023 at 07:02, 2 years 8 months ago

bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion

Accesswire

Published on 07/08/2026 at 16:45, 1 hour 10 minutes ago

Change Of Record Date for Special Meeting
Published on 07/08/2026 at 15:25, 2 hours 30 minutes ago

Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 2 hours 55 minutes ago

Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 2 hours 55 minutes ago

GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 14:30, 3 hours 25 minutes ago

Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

View all ACCESSWIRE

EQS Group

Published on 07/08/2026 at 15:42, 2 hours 12 minutes ago

EQS-Adhoc: Kapsch TrafficCom signs agreement on the sale of a majority stake in German subsidiary and is therefore expecting a significant impact on EBIT.
Published on 07/08/2026 at 15:22, 2 hours 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/08/2026 at 15:21, 2 hours 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 07/08/2026 at 15:21, 2 hours 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 07/08/2026 at 15:20, 2 hours 34 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

Les Echos

Published on 07/08/2026 at 17:45, 10 minutes ago

Half-year liquidity contract statement of ALTEN SA as at 30 June 2026
Published on 07/08/2026 at 17:40, 15 minutes ago

Report on share repurchases from 1 to 7 July 2026
Published on 07/08/2026 at 11:15, 6 hours 40 minutes ago

Half-year statement of the liquidity contract H1 2026
Published on 07/07/2026 at 19:53, 22 hours 1 minute ago

GROUPE SFPI: New Deputy Managing Director
Published on 07/07/2026 at 18:10, 23 hours 44 minutes ago

LNA Santé and Euryale join forces to expand hospitalisation at home services across healthcare regions

View all LES ECHOS COMFI WIRE